Home › Funds › TANG CAPITAL MANAGEMENT LLC › HRTX
TANG CAPITAL MANAGEMENT LLC position in HRTX
HERON THERAPEUTICS INC · Health Care
TANG CAPITAL MANAGEMENT LLC reported holding 8,971,427 shares of HRTX (HERON THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.8M, representing 0.13% of its reported portfolio and ranking #39 among its reported holdings. TANG CAPITAL MANAGEMENT LLC has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How TANG CAPITAL MANAGEMENT LLC's HRTX position evolved
TANG CAPITAL MANAGEMENT LLC first disclosed a stake in HRTX in Q3 2023 at 1,850,000 shares (US$1.9M). The position peaked in Q4 2025 at 6,250,000 shares, worth US$8.1M. Across 13 filings, TANG CAPITAL MANAGEMENT LLC increased the stake 5 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 8,971,427 shares valued at US$2.8M — an increase of 2,721,427 shares quarter over quarter.. Notable position changes include a 62% increase in Q3 2025 (shares rose 3% over the following quarter), a 81% increase in Q4 2025 (shares fell 38% over the following quarter), a 44% increase in Q3 2026 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.85M | $1.91M | New |
| Q4 2023 | 1.85M | $3.15M | Hold |
| Q1 2024 | 1.85M | $5.12M | Hold |
| Q2 2024 | 1.85M | $6.47M | Hold |
| Q3 2024 | 1.85M | $3.68M | Hold |
| Q4 2024 | 2.14M | $3.27M | Add |
| Q1 2025 | 2.24M | $4.92M | Add |
| Q2 2025 | 2.14M | $4.42M | Reduce |
| Q3 2025 | 3.45M | $4.35M | Add |
| Q4 2025 | 6.25M | $8.12M | Add |
| Q1 2026 | 6.25M | $5.00M | Hold |
| Q2 2026 | 6.25M | $2.67M | Hold |
| Q3 2026 | 8.97M | $2.81M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HRTX and 13F data
HRTX (HERON THERAPEUTICS INC) is a Health Care company. 6 other funds we track also report a position in HRTX — the largest reported positions include Velan Capital Investment Management LP (US$2.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HRTX
- Velan Capital Investment Management LP 8.75M sh · $2.74M · Q3 2026
More on TANG CAPITAL MANAGEMENT LLC
FAQ
How long has TANG CAPITAL MANAGEMENT LLC held HRTX?
TANG CAPITAL MANAGEMENT LLC has disclosed HRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is TANG CAPITAL MANAGEMENT LLC's current position in HRTX?
As of Q3 2026, TANG CAPITAL MANAGEMENT LLC holds 8.97M shares of HRTX (HERON THERAPEUTICS INC), valued at $2.81M, representing 0.13% of its reported portfolio and ranking #39.
Has TANG CAPITAL MANAGEMENT LLC been buying or selling HRTX?
In the latest 13F filing (Q3 2026), TANG CAPITAL MANAGEMENT LLC increased its position in HRTX. The position peaked in Q4 2025 at 6.25M shares.
Which other funds hold HRTX?
Other major institutional holders of HRTX include Velan Capital Investment Management LP, among 6 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.